GURNEE, Ill., Aug. 16, 2022 /PRNewswire/ -- Akorn Operating Company LLC, a specialty pharmaceutical company, announces that it received FDA approval for a generic version of Cetrorelix Acetate for ...
License fees include periodic milestone payments, research and development contract fees and the amortization of upfront payments received from licensing partners. Merck KGaA’s subsidiary Merck Serono ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback